ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
34.74
+0.37 (1.08%)
Jun 30, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $45 | Buy | Maintains | $45 | +29.53% | Jun 4, 2026 |
| Citi | Citi | Buy Maintains $43 | Buy | Maintains | $43 | +23.78% | Jun 4, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $45 | Buy | Maintains | $45 | +29.53% | Jun 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 | Buy | Reiterates | $50 | +43.93% | Jun 1, 2026 |
| Truist Financial | Truist Financial | Buy Initiates $43 → $45 | Buy | Initiates | $43 → $45 | +29.53% | May 29, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $45 | Buy | Maintains | $45 | +29.53% | May 29, 2026 |
| BTIG | BTIG | Buy Maintains $42 | Buy | Maintains | $42 | +20.90% | May 29, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $42 | Buy | Maintains | $42 | +20.90% | May 17, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.